SciVision Biotech Inc. (TPE:1786)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
71.60
-0.60 (-0.83%)
Feb 11, 2026, 1:30 PM CST
Market Cap5.17B -40.0%
Revenue (ttm)890.43M +7.1%
Net Income164.72M -23.7%
EPS2.24 -23.4%
Shares Out72.19M
PE Ratio31.99
Forward PEn/a
Dividend3.25 (4.54%)
Ex-Dividend DateApr 25, 2025
Volume274,211
Average Volume296,638
Open72.00
Previous Close72.20
Day's Range71.10 - 72.00
52-Week Range71.10 - 129.50
Beta0.53
RSI31.60
Earnings DateMar 6, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2024, SciVision Biotech's revenue was 883.31 million, an increase of 23.89% compared to the previous year's 712.99 million. Earnings were 242.25 million, an increase of 36.17%.

Financial Statements